Literature DB >> 11224598

Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.

W R Macon1, N B Levy, P J Kurtin, K E Salhany, M Y Elkhalifa, T T Casey, F E Craig, C L Vnencak-Jones, M L Gulley, J P Park, J B Cousar.   

Abstract

Hepatosplenic gammadelta T-cell lymphoma is a distinct entity, characterized by occurrence in young adult males with hepatosplenomegaly, B-symptoms, peripheral blood cytopenias, and no lymphadenopathy; lymphomatous infiltrates in the splenic red pulp, hepatic sinusoids, and bone marrow sinuses; T-cell receptor (TCR) gammadelta chains and a cytotoxic T-cell phenotype; isochromosome 7q; and an aggressive clinical course. In comparison, this study describes the clinicopathologic features of 14 hepatosplenic T-cell lymphomas expressing TCR alphabeta chains. They occurred in 11 women and 3 men with a median age of 36 years. Clinical presentation was similar to that described previously for hepatosplenic gammadelta T-cell lymphomas, except for the female preponderance and age distribution (5 patients younger than 13 years of age and 5 patients older than 50 years of age). Disease distribution was primarily in the splenic red pulp and hepatic sinusoids, although liver infiltrates were largely periportal in four cases. Bone marrow involvement, observed in eight patients, was usually interstitial and/or within the sinuses. Lymph nodes were involved in five patients, although lymphadenopathy was demonstrable in only two. Ten cases were composed of intermediate-size tumor cells with round/oval nuclei, slightly dispersed chromatin, inconspicuous nucleoli, and scant to moderate amounts of cytoplasm. Four lymphomas contained primarily large cells with irregular nuclei, dispersed chromatin, discernible nucleoli, and moderate to abundant cytoplasm. Tumor cells in all 14 lymphomas were cytotoxic alphabeta T-cells; 13 co-expressed natural killer cell-associated antigens and showed T-cell clonality. Three lymphomas were associated with Epstein-Barr virus. Two of four cases had an isochromosome 7q. Eleven patients are dead, eight within a year of diagnosis, and two patients have maintained complete remissions after combination chemotherapy. These data show that hepatosplenic T-cell lymphomas include an alphabeta-subtype. This group, along with the previously recognized gammadelta group, should be recognized as phenotypically heterogeneous subtypes of the same disease entity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11224598     DOI: 10.1097/00000478-200103000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  35 in total

1.  Hepatosplenic αβ T-cell lymphoma associated with azathioprine therapy.

Authors:  Armin Rashidi; Michael E Lee; Stephen I Fisher
Journal:  Int J Hematol       Date:  2012-04-22       Impact factor: 2.490

Review 2.  [Malignant lymphomas of the liver: new diagnostic algorithms].

Authors:  T Longerich; P Schirmacher; H P Dienes; H Stein; C Loddenkemper
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

3.  Issue editor.

Authors:  A Burshell
Journal:  Ochsner J       Date:  2001-07

4.  Hepatosplenic T-cell lymphoma.

Authors:  Fahad I Alsohaibani; Maheeba A Abdulla; Mousa M Fagih
Journal:  Indian J Hematol Blood Transfus       Date:  2011-02-12       Impact factor: 0.900

5.  Hepatosplenic alphabeta T cell lymphoma.

Authors:  Yuya Nagai; Kazuhiro Ikegame; Minako Mori; Daichi Inoue; Takaharu Kimura; Sonoko Shimoji; Katsuhiro Togami; Sumie Tabata; Masayuki Kurata; Yukihiro Imai; Akiko Matsushita; Kenichi Nagai; Hiroyasu Ogawa; Takayuki Takahashi
Journal:  Int J Clin Oncol       Date:  2010-03-10       Impact factor: 3.402

Review 6.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

7.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

Review 8.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

Review 9.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

10.  Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization.

Authors:  Andrew L Feldman; Mark Law; Karen L Grogg; Erik C Thorland; Stephanie Fink; Paul J Kurtin; William R Macon; Ellen D Remstein; Ahmet Dogan
Journal:  Am J Clin Pathol       Date:  2008-08       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.